Arvinas, Inc. (ARVN) vs Indaptus Therapeutics, Inc. (INDP)
- Arvinas, Inc. ARVN 7.56 −3.82%
- Indaptus Therapeutics, Inc. INDP 3.47 +12.30%
Arvinas, Inc. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and Indaptus Therapeutics, Inc. are of similar size ($513.9M and $474.6M). Indaptus Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 41.0×. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Arvinas, Inc. leads on 7 and Indaptus Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ARVN | INDP | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 0.00% | 68.94% |
| Operating margin | (5.72%) | 0.00% | 0.00% |
| Net margin | 2.94% | 0.00% | 0.00% |
| Free cash flow margin | (65.93%) | 0.00% | 0.00% |
| Return on equity | 1.59% | (318.04%) | (54.09%) |
| Return on assets | 1.17% | (163.84%) | (46.84%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack